A pilot case-control study on the fecal microbiota of pediatric functional abdominal pain-not otherwise specified and the role of early life stress

Nize Otaru , Benoît Pugin , Serafina Plüss , Iva Hojsak , Christian Braegger , Christophe Lacroix

Microbiome Research Reports ›› 2024, Vol. 3 ›› Issue (3) : 32

PDF
Microbiome Research Reports ›› 2024, Vol. 3 ›› Issue (3) :32 DOI: 10.20517/mrr.2023.75
Original Article

A pilot case-control study on the fecal microbiota of pediatric functional abdominal pain-not otherwise specified and the role of early life stress

Author information +
History +
PDF

Abstract

Background: Gut microbial features and the role of early life stress in pediatric functional abdominal pain-not otherwise specified (FAP-NOS) have never been investigated before. Here, we hypothesize that early life stress is more prevalent in FAP-NOS compared to healthy controls and that fecal microbial profiles and related metabolites differ between groups.

Methods: In an international multicenter case-control study, FAP-NOS patients (n = 40) were compared to healthy controls (n = 55). Stool samples and demographic and clinical data including early life traumatic events and antibiotics treatments were collected from children aged four to twelve years. Fecal microbial profiles were assessed with 16S rRNA gene amplicon sequencing. Microbial metabolite concentrations in fecal supernatant, including short-chain fatty acids and amino acids, were detected via liquid chromatography.

Results: Microbial richness was increased in FAP-NOS compared to healthy controls and microbial composition (unweighted UniFrac) differed between groups. Three distinct amplicon sequencing variants and two distinct species were enriched in FAP-NOS compared to controls, with no observed changes at higher taxonomic levels. No differences in microbial metabolites and early life stress were observed between groups.

Conclusion: The presented hypothesis could not be proven, with no observed differences in occurrence of early life stress, and fecal microbial metabolic profiles between pediatric FAP-NOS and healthy controls. Pediatric FAP-NOS patients exhibited mild differences in the fecal microbial community compared with controls. Further large-scale studies with high-resolution techniques are warranted to address the biological relevance of present observations.

Keywords

Functional abdominal pain / functional abdominal pain not otherwise specified / fecal microbiota / fecal metabolites / early life stress

Cite this article

Download citation ▾
Nize Otaru, Benoît Pugin, Serafina Plüss, Iva Hojsak, Christian Braegger, Christophe Lacroix. A pilot case-control study on the fecal microbiota of pediatric functional abdominal pain-not otherwise specified and the role of early life stress. Microbiome Research Reports, 2024, 3(3): 32 DOI:10.20517/mrr.2023.75

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Korterink JJ,Benninga MA.Epidemiology of pediatric functional abdominal pain disorders: a meta-analysis.PLoS One2015;10:e0126982 PMCID:PMC4439136

[2]

Thapar N,Crowell MD.Paediatric functional abdominal pain disorders.Nat Rev Dis Primers2020;6:89

[3]

Hyams JS,Saps M,Staiano A.Functional disorders: children/adolescents.Gastroenterology2016;150:1456-68.e2

[4]

Drossman DA.Rome IV-functional GI disorders: disorders of gut-brain interaction.Gastroenterology2016;150:1257-61

[5]

Willits AB,Glidden NC,Young EE.Identification of a pain-specific gene expression profile for pediatric recurrent abdominal pain.Front Pain Res2021;2:759634 PMCID:PMC8915586

[6]

Henström M.Genetics of irritable bowel syndrome.Mol Cell Pediatr2016;3:7 PMCID:PMC4752571

[7]

Levy RL,Whitehead WE,Talley NJ.Irritable bowel syndrome in twins: heredity and social learning both contribute to etiology.Gastroenterology2001;121:799-804

[8]

Zeevenhooven J,van Dijk M,Benninga MA.Parental factors in pediatric functional abdominal pain disorders: a cross-sectional cohort study.J Pediatr Gastroenterol Nutr2019;68:e20-6

[9]

Jena A,Mullaney JA.Gut-brain axis in the early postnatal years of life: a developmental perspective.Front Integr Neurosci2020;14:44 PMCID:PMC7419604

[10]

Bradford K,Videlock EJ.Association between early adverse life events and irritable bowel syndrome.Clin Gastroenterol Hepatol2012;10:385-90.e1-3 PMCID:PMC3311761

[11]

Uusijärvi A,Simrén M.Use of antibiotics in infancy and childhood and risk of recurrent abdominal pain--a Swedish birth cohort study.Neurogastroenterol Motil2014;26:841-50

[12]

Duan R,Wang B.Alterations of gut microbiota in patients with irritable bowel syndrome based on 16S rRNA-targeted sequencing: a systematic review.Clin Transl Gastroenterol2019;10:e00012 PMCID:PMC6407812

[13]

Abomoelak B,Deb C.The gut microbiome alterations in pediatric patients with functional abdominal pain disorders.Microorganisms2021;9:2354 PMCID:PMC8622193

[14]

Saulnier DM,Mistretta TA.Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome.Gastroenterology2011;141:1782-91 PMCID:PMC3417828

[15]

Hollister EB,Chumpitazi BP.Leveraging human microbiome features to diagnose and stratify children with irritable bowel syndrome.J Mol Diagn2019;21:449-61 PMCID:PMC6504675

[16]

Rutten JM,Vlieger AM.IBS and FAPS in children: a comparison of psychological and clinical characteristics.J Pediatr Gastroenterol Nutr2014;59:493-9

[17]

Schmidt SJ,Lory I.Age-related effects of the COVID-19 pandemic on mental health of children and adolescents.Eur J Psychotraumatol2021;12:1901407 PMCID:PMC8075089

[18]

Scheeringa M. Young child PTSD checklist. 2013. Available from: https://www.michaelscheeringa.com/uploads/1/2/0/2/120202234/ycpc_2014_5_23.pdf. [Last accessed on 4 Jun 2024]

[19]

Landolt MA,Maier T,Mohler-Kuo M.Trauma exposure and posttraumatic stress disorder in adolescents: a national survey in Switzerland.J Trauma Stress2013;26:209-16

[20]

Steinberg AM,Kim S.Psychometric properties of the UCLA PTSD reaction index: part I.J Trauma Stress2013;26:1-9

[21]

Paganini D,Kortman GAM.Prebiotic galacto-oligosaccharides mitigate the adverse effects of iron fortification on the gut microbiome: a randomised controlled study in Kenyan infants.Gut2017;66:1956-67

[22]

Otaru N,Mujezinovic D.GABA production by human intestinal Bacteroides spp.: prevalence, regulation, and role in acid stress tolerance.Front Microbiol2021;12:656895 PMCID:PMC8082179

[23]

Constancias F.Fconstancias/metabaRpipe: v0.9. Zenodo.

[24]

Didion JP,Collins FS.Atropos: specific, sensitive, and speedy trimming of sequencing reads.PeerJ2017;5:e3720 PMCID:PMC5581536

[25]

Callahan BJ,Rosen MJ,Johnson AJ.DADA2: High-resolution sample inference from Illumina amplicon data.Nat Methods2016;13:581-3 PMCID:PMC4927377

[26]

The Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome.Nature2012;486:207-14 PMCID:PMC3564958

[27]

Le Chatelier E, Nielsen T, Qin J, et al; MetaHIT consortium. Richness of human gut microbiome correlates with metabolic markers.Nature2013;500:541-6

[28]

Arumugam M, Raes J, Pelletier E, et al; MetaHIT Consortium. Enterotypes of the human gut microbiome.Nature2011;473:174-80 PMCID:PMC3728647

[29]

The R Project for statistical computing. Available from: https://www.r-project.org/. [Last accessed on 27 May 2024]

[30]

McLaren M. speedyseq: faster implementations of phyloseq functions. Available from: https://github.com/mikemc/speedyseq. [Last accessed on 27 May 2024]

[31]

Oksanen J,Blanchet FG et al. vegan: Community Ecology Package. Available from: https://cran.r-project.org/web/packages/vegan/index.html. [Last accessed on 27 May 2024]

[32]

Paradis E.ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R.Bioinformatics2019;35:526-8

[33]

Andersen KS,Karst SM. ampvis2: an R package to analyse and visualise 16S rRNA amplicon data. bioRXiv. [Preprint.] Apr 11, 2018 [accessed 2024 May 27]. Available from: https://www.biorxiv.org/content/10.1101/299537v1.

[34]

Constancias F. fconstancias/DivComAnalyses: v0.9. Zenodo. 2022. Available from: https://zenodo.org/records/6473394. [Last accessed on 27 May 2024]

[35]

Mallick H,McIver LJ.Multivariable association discovery in population-scale meta-omics studies.PLoS Comput Biol2021;17:e1009442 PMCID:PMC8714082

[36]

Douglas GM,Zaneveld JR.PICRUSt2 for prediction of metagenome functions.Nat Biotechnol2020;38:685-8 PMCID:PMC7365738

[37]

Caspi R,Ferrer L.The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases.Nucleic Acids Res2016;44:D471-80 PMCID:PMC4702838

[38]

Vandeputte D,Vieira-Silva S,Joossens M.Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates.Gut2016;65:57-62 PMCID:PMC4717365

[39]

Firrman J,Mahalak K.The impact of environmental pH on the gut microbiota community structure and short chain fatty acid production.FEMS Microbiol Ecol2022;98:fiac038

[40]

Wickham H,Pedersen TL. ggplot2: elegant graphics for data analysis (3e). New York: Springer. 2016. Available from: https://ggplot2-book.org/. [Last accessed on 27 May 2024]

[41]

Gu Z,Schlesner M.Complex heatmaps reveal patterns and correlations in multidimensional genomic data.Bioinformatics2016;32:2847-9

[42]

Melchior M,Poisbeau P.The burden of early life stress on the nociceptive system development and pain responses.Eur J Neurosci2022;55:2216-41

[43]

Zhong H,Shi Z.Impact of early events and lifestyle on the gut microbiota and metabolic phenotypes in young school-age children.Microbiome2019;7:2 PMCID:PMC6320620

[44]

Costea PI,Arumugam M.Enterotypes in the landscape of gut microbial community composition.Nat Microbiol2018;3:8-16 PMCID:PMC5832044

[45]

Smith EA.Enumeration of amino acid fermenting bacteria in the human large intestine: effects of pH and starch on peptide metabolism and dissimilation of amino acids.FEMS Microbiol Ecol1998;25:355-68

[46]

David LA,Carmody RN.Diet rapidly and reproducibly alters the human gut microbiome.Nature2014;505:559-63 PMCID:PMC3957428

[47]

Larsen OFA.The mechanistic link between health and gut microbiota diversity.Sci Rep2018;8:2183 PMCID:PMC5794854

[48]

Vijay A.Role of the gut microbiome in chronic diseases: a narrative review.Eur J Clin Nutr2022;76:489-501 PMCID:PMC8477631

[49]

Kim MH,Kim J.Gut microbiota and metabolic health among overweight and obese individuals.Sci Rep2020;10:19417 PMCID:PMC7655835

[50]

Rigsbee L,Shankar V.Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome.Am J Gastroenterol2012;107:1740-51

[51]

Barandouzi ZA,Maas K,Cong XS.Altered gut microbiota in irritable bowel syndrome and its association with food components.J Pers Med2021;11:35 PMCID:PMC7827153

[52]

Manor O,Kornilov SA.Health and disease markers correlate with gut microbiome composition across thousands of people.Nat Commun2020;11:5206 PMCID:PMC7562722

[53]

Mars RAT,Ward T.Longitudinal multi-omics reveals subset-specific mechanisms underlying irritable bowel syndrome.Cell2020;182:1460-73.e17 PMCID:PMC8109273

[54]

Crowther JS.Sarcina ventriculi in human faeces.J Med Microbiol1971;4:343-50

[55]

Tartaglia D,Mazzoni A.Sarcina ventriculi infection: a rare but fearsome event. a systematic review of the literature.Int J Infect Dis2022;115:48-61

[56]

Guandalini S,Chiaro A.VSL#3 improves symptoms in children with irritable bowel syndrome: a multicenter, randomized, placebo-controlled, double-blind, crossover study.J Pediatr Gastroenterol Nutr2010;51:24-30

[57]

Giannetti E,Alessandrella A.A mixture of 3 bifidobacteria decreases abdominal pain and improves the quality of life in children with irritable bowel syndrome: a multicenter, randomized, double-blind, placebo-controlled, crossover trial.J Clin Gastroenterol2017;51:e5-10

[58]

Guglielmetti S,Gschwender M.Randomised clinical trial: Bifidobacterium bifidum MIMBb75 significantly alleviates irritable bowel syndrome and improves quality of life--a double-blind, placebo-controlled study.Aliment Pharmacol Ther2011;33:1123-32

[59]

Ventura M,Casale AD.Analysis of bifidobacterial evolution using a multilocus approach.Int J Syst Evol Microbiol2006;56:2783-92

[60]

Alessandri G,Ventura M.The genus bifidobacterium: from genomics to functionality of an important component of the mammalian gut microbiota running title: Bifidobacterial adaptation to and interaction with the host.Comput Struct Biotechnol J2021;19:1472-87 PMCID:PMC7979991

[61]

Johnson JS,Hong BY.Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis.Nat Commun2019;10:5029 PMCID:PMC6834636

[62]

Bosch S,Zuurbier RP.Differentiation between pediatric irritable bowel syndrome and inflammatory bowel disease based on fecal scent: proof of principle study.Inflamm Bowel Dis2018;24:2468-75

[63]

Shankar V,Rigsbee L.The networks of human gut microbe-metabolite associations are different between health and irritable bowel syndrome.ISME J2015;9:1899-903 PMCID:PMC4511929

[64]

Roswall J,Kovatcheva-Datchary P.Developmental trajectory of the healthy human gut microbiota during the first 5 years of life.Cell Host Microbe2021;29:765-76.e3

[65]

Tang Q,Wang G.Current sampling methods for gut microbiota: a call for more precise devices.Front Cell Infect Microbiol2020;10:151 PMCID:PMC7161087

[66]

Dieterich W,Zopf Y.Microbiota in the gastrointestinal tract.Med Sci2018;6:116 PMCID:PMC6313343

[67]

Falony G,Vieira-Silva S.Population-level analysis of gut microbiome variation.Science2016;352:560-4

[68]

Erben V,Schrotz-King P.Evaluation of different stool extraction methods for metabolomics measurements in human faecal samples.BMJ Nutr Prev Health2021;4:374-84 PMCID:PMC8718864

[69]

Cui M,Castro-Mejía JL.Human fecal metabolome reflects differences in body mass index, physical fitness, and blood lipoproteins in healthy older adults.Metabolites2021;11:717 PMCID:PMC8620003

[70]

Heim C.Stress, early life. In: Gellman MD, Turner JR, editors. Encyclopedia of behavioral medicine. New York: Springer; 2013. pp. 1903-6.

AI Summary AI Mindmap
PDF

137

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/